2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $11B | $13B | $14B | $15B | $15B |
Cost of Revenue | $6.9B | $8.3B | $9.2B | $9.3B | $9.5B |
Gross Profit | $3.8B | $4.5B | $5B | $5.2B | $5.4B |
Gross Profit % | 35% | 35% | 35% | 36% | 36% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $749M | $997M | $1.1B | $1.1B | $1.1B |
Dep. & Amort. | $217M | $270M | $343M | $393M | $447M |
Def. Tax | -$32M | $29M | $52M | $6.2M | -$23M |
Stock Comp. | $37M | $48M | $54M | $57M | $48M |
Chg. in WC | $350M | -$209M | -$182M | -$181M | -$91M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.3B | $878M | $203M | $397M | $251M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $1.3B | $878M | $203M | $397M | $251M |
Receivables | $1 | $17M | $0 | $2.5M | $0 |
Inventory | $1.8B | $2.2B | $2.7B | $2.6B | $2.8B |
Q1 total sales reached a record $3.47B (+2.1% YoY), but comparable store sales declined 0.9% due to delayed spring weather, with strong transaction growth (+2.1%) offset by a 2.9% decline in average ticket.
Updated FY25 guidance: net sales growth of 4-8%, comparable store sales flat to +4%, operating margin of 9.5%-9.9%, net income of $1.07B-$1.17B, and EPS of $2.00-$2.18; Q2 guidance: net sales growth of 3-4%, comps flat to +1%, and EPS of $0.79-$0.81.
Tariff impact: Guidance assumes current tariffs (10% non-China, 45% China) for Q2 receipts only, with potential cost pass-throughs in the second half; company is not currently taking price increases but expects vendor cost pressures to rise.
Core business remains resilient with robust transaction growth, record customer retention, and strong unit growth in consumable, usable, and edible categories; big ticket and spring seasonal categories remain pressured.
Strategic initiatives progressing: successful launch of Tractor Supply Rx (pet prescriptions), continued market share gains in feed and pet categories, and ongoing supply chain diversification to reduce China exposure below 50% by year-end.